PUBLIC CONTRACT · 2020
4150007/2020 - MEGEST.160 mg comp, ERLOT.150 mg comp revest, MITOMI.40 mg frs/AMP,SUNITINIB50MG CP
- Contract value
- €5,040.00
- Signed on
- 17 March 2020
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6482016PUBLISHED SUBJECT
4150007/2020 - MEGEST.160 MG COMP, ERLOT.150 MG COMP REVEST, MITOMI.40 MG FRS/AMP,SUNITINIB50MG CP
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Generis Farmacêutica, SA · Tax ID 508107997
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €5,040.00
- Procedure base price
- €29,129.27
- Total effective price
- €5,040.00
- Publication date
- 13 April 2020
- Award date
- 17 March 2020
- Signing date
- 17 March 2020
- Performance period
- 2 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 2o, n.º 1 do DL . no 10-A/2020, de 13.03
- Regime
- Decreto-Lei n.º 10-A/2020, de 13.03
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4481740
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.